This evidence only partially fits with the results presented here, but it can suggest that the cellular origin of circulating PDE5 could not only be in the tumoral area but also in the neighboring tissue, including tumor-infiltrating immune cells, or even in more distant sites. This evidence concerns the gene PDE5A and neoplasm.